A new weapon for attacking tumor blood vessels

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


The vascular endothelial growth factor is the target of the antiangiogenic drug bevacizumab. Another protein, placental growth factor, also represents a promising target for countering tumor angiogenesis.

Original languageEnglish (US)
Pages (from-to)2066
Number of pages1
JournalNew England Journal of Medicine
Issue number19
StatePublished - May 8 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'A new weapon for attacking tumor blood vessels'. Together they form a unique fingerprint.

Cite this